Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Icu Medical Inc/de (ICUI) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Icu Medical Inc/de. Table 2 shows the detailed insider transactions. This company's CIK number is 883984.
Total stock buying since 2015: $8,955,465.
Total stock sales since 2015: $1,269,773,208.
Total stock option exercises since 2015: $45,700,289.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 23,129 | $2,619,150 | 43,988 | $5,899,904 | 90,217 | $4,477,105 |
| 2024 | 0 | $0 | 1,820,876 | $197,727,120 | 398,968 | $18,978,501 |
| 2023 | 0 | $0 | 71,212 | $12,649,701 | 119,061 | $3,527,400 |
| 2022 | 25,835 | $4,469,067 | 36,967 | $8,807,175 | 146,146 | $7,031,053 |
| 2021 | 0 | $0 | 203,864 | $44,683,445 | 175,801 | $8,062,085 |
| 2020 | 0 | $0 | 158,122 | $31,089,730 | 124,576 | $3,490,825 |
| 2019 | 0 | $0 | 115,414 | $23,651,959 | 106,805 | $0 |
| 2018 | 0 | $0 | 3,498,560 | $804,606,598 | 29,996 | $0 |
| 2017 | 12,000 | $1,867,248 | 357,678 | $62,638,289 | 49,330 | $0 |
| 2016 | 0 | $0 | 269,854 | $31,008,094 | 10,219 | $0 |
| 2015 | 0 | $0 | 478,948 | $47,011,193 | 40,798 | $133,320 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 23,129 | $2,619,150 | 0 | $0 | 0 | $0 |
| 2025-05 | 0 | $0 | 43,988 | $5,899,904 | 56,725 | $4,477,105 |
| 2025-03 | 0 | $0 | 0 | $0 | 33,492 | $0 |
| 2024-12 | 0 | $0 | 14,241 | $2,307,862 | 12,000 | $1,065,120 |
| 2024-11 | 0 | $0 | 24,083 | $4,010,271 | 24,083 | $2,233,024 |
| 2024-10 | 0 | $0 | 12,000 | $2,146,884 | 12,000 | $1,065,120 |
| 2024-09 | 0 | $0 | 12,000 | $1,961,412 | 12,000 | $1,065,120 |
| 2024-08 | 0 | $0 | 16,552 | $2,576,276 | 12,000 | $1,065,120 |
| 2024-05 | 0 | $0 | 14,839 | $1,548,774 | 5,688 | $0 |
| 2024-03 | 0 | $0 | 67,161 | $7,091,141 | 108,831 | $0 |
| 2024-02 | 0 | $0 | 1,660,000 | $176,084,500 | 212,366 | $12,484,997 |
| 2023-12 | 0 | $0 | 1,729 | $152,196 | 0 | $0 |
| 2023-09 | 0 | $0 | 6,850 | $885,766 | 0 | $0 |
| 2023-07 | 0 | $0 | 30,000 | $5,400,720 | 30,000 | $1,763,700 |
| 2023-06 | 0 | $0 | 30,194 | $5,743,209 | 30,000 | $1,763,700 |
| 2023-05 | 0 | $0 | 0 | $0 | 2,910 | $0 |
| 2023-04 | 0 | $0 | 708 | $121,610 | 0 | $0 |
| 2023-03 | 0 | $0 | 0 | $0 | 56,151 | $0 |
| 2023-02 | 0 | $0 | 1,731 | $346,200 | 0 | $0 |
| 2022-09 | 0 | $0 | 0 | $0 | 79,576 | $4,914,613 |
| 2022-05 | 25,835 | $4,469,067 | 967 | $167,175 | 2,213 | $0 |
| 2022-03 | 0 | $0 | 36,000 | $8,640,000 | 64,357 | $2,116,440 |
| 2021-12 | 0 | $0 | 12,000 | $2,880,010 | 12,000 | $705,478 |
| 2021-11 | 0 | $0 | 24,000 | $5,760,048 | 24,000 | $1,410,960 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-27 | Greenberg David C. (Director) | Buy | 1,200 | 126.42 | 151,699 |
| 2025-08-14 | Jain Vivek (Chairman and CEO) | Buy | 21,929 | 112.52 | 2,467,451 |
| 2025-05-30 | Sanzone Virginia Ruth (VP, General Counsel) | Sale | 700 | 133.62 | 93,536 |
| 2025-05-28 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 4,985 | 128.50 | 640,577 |
| 2025-05-28 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 5,560 | 96.83 | 538,374 |
| 2025-05-27 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 4,945 | 131.00 | 647,795 |
| 2025-05-27 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 5,555 | 96.83 | 537,890 |
| 2025-05-23 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 4,959 | 130.00 | 644,670 |
| 2025-05-23 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 5,555 | 96.83 | 537,890 |
| 2025-05-22 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 4,959 | 130.03 | 644,833 |
| 2025-05-22 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 5,555 | 96.83 | 537,890 |
| 2025-05-21 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 4,917 | 133.00 | 653,961 |
| 2025-05-21 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 5,555 | 96.83 | 537,890 |
| 2025-05-20 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 4,871 | 137.11 | 667,877 |
| 2025-05-20 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 5,555 | 96.83 | 537,890 |
| 2025-05-19 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 5,555 | 138.00 | 766,612 |
| 2025-05-19 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 5,555 | 96.83 | 537,890 |
| 2025-05-19 | Finney Elisha W | Sale | 600 | 138.92 | 83,352 |
| 2025-05-16 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 5,555 | 140.00 | 777,700 |
| 2025-05-16 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 5,555 | 96.83 | 537,890 |
| 2025-05-13 | Hernandez Laurie (Director) | Option Ex | 1,723 | .00 | 0 |
| 2025-05-13 | Greenberg David C. (Director) | Sale | 1,942 | 143.66 | 278,991 |
| 2025-05-13 | Greenberg David C. (Director) | Option Ex | 3,665 | 47.34 | 173,501 |
| 2025-05-13 | Abbey Donald | Option Ex | 1,723 | .00 | 0 |
| 2025-05-13 | Kennedy Kolleen T | Option Ex | 1,723 | .00 | 0 |
| 2025-05-13 | Hoffmeister David F | Option Ex | 1,723 | .00 | 0 |
| 2025-05-13 | Finney Elisha W | Option Ex | 1,723 | .00 | 0 |
| 2025-03-15 | Sousa Ben (Chief Information Officer) | Option Ex | 1,299 | .00 | 0 |
| 2025-03-15 | Bonnell Brian Michael (Chief Financial Officer) | Option Ex | 3,248 | .00 | 0 |
| 2025-03-15 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 3,248 | .00 | 0 |
| 2025-03-15 | Woolson Daniel (VP, GM-Infusion Capital) | Option Ex | 2,923 | .00 | 0 |
| 2025-03-15 | Sanzone Virginia Ruth (VP, General Counsel) | Option Ex | 1,624 | .00 | 0 |
| 2025-03-15 | Jain Vivek (Chairman and CEO) | Option Ex | 4,872 | .00 | 0 |
| 2025-03-08 | Sousa Ben (Chief Information Officer) | Option Ex | 957 | .00 | 0 |
| 2025-03-08 | Woolson Daniel (VP, GM-Infusion Capital) | Option Ex | 2,153 | .00 | 0 |
| 2025-03-08 | Sanzone Virginia Ruth (VP, General Counsel) | Option Ex | 3,189 | .00 | 0 |
| 2025-03-07 | Sousa Ben (Chief Information Officer) | Option Ex | 430 | .00 | 0 |
| 2025-03-07 | Bonnell Brian Michael (Chief Financial Officer) | Option Ex | 2,146 | .00 | 0 |
| 2025-03-07 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 2,146 | .00 | 0 |
| 2025-03-07 | Woolson Daniel (VP, GM-Infusion Capital) | Option Ex | 966 | .00 | 0 |
| 2025-03-07 | Sanzone Virginia Ruth (VP, General Counsel) | Option Ex | 1,073 | .00 | 0 |
| 2025-03-07 | Jain Vivek (Chairman and CEO) | Option Ex | 3,218 | .00 | 0 |
| 2024-12-06 | Woolson Daniel (VP, GM-Infusion Capital) | Sale | 2,241 | 156.25 | 350,158 |
| 2024-12-02 | Jain Vivek (Chairman and CEO) | Sale | 12,000 | 163.14 | 1,957,704 |
| 2024-12-02 | Jain Vivek (Chairman and CEO) | Option Ex | 12,000 | 88.76 | 1,065,120 |
| 2024-11-27 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 1,430 | 158.00 | 225,935 |
| 2024-11-27 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 1,430 | 96.83 | 138,466 |
| 2024-11-27 | Greenberg David C. (Director) | Sale | 972 | 158.11 | 153,682 |
| 2024-11-27 | Greenberg David C. (Director) | Option Ex | 972 | 94.68 | 92,028 |
| 2024-11-26 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 7,719 | 159.59 | 1,231,867 |
| 2024-11-26 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 7,719 | 96.83 | 747,430 |
| 2024-11-25 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 1,962 | 169.08 | 331,727 |
| 2024-11-25 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 1,962 | 96.83 | 189,980 |
| 2024-11-01 | Jain Vivek (Chairman and CEO) | Sale | 12,000 | 172.25 | 2,067,060 |
| 2024-11-01 | Jain Vivek (Chairman and CEO) | Option Ex | 12,000 | 88.76 | 1,065,120 |
| 2024-10-01 | Jain Vivek (Chairman and CEO) | Sale | 12,000 | 178.91 | 2,146,884 |
| 2024-10-01 | Jain Vivek (Chairman and CEO) | Option Ex | 12,000 | 88.76 | 1,065,120 |
| 2024-09-03 | Jain Vivek (Chairman and CEO) | Sale | 12,000 | 163.45 | 1,961,412 |
| 2024-09-03 | Jain Vivek (Chairman and CEO) | Option Ex | 12,000 | 88.76 | 1,065,120 |
| 2024-08-30 | Woolson Daniel (VP, GM-Infusion Capital) | Sale | 2,502 | 163.22 | 408,371 |
| 2024-08-16 | Jain Vivek (Chairman and CEO) | Sale | 12,000 | 156.04 | 1,872,480 |
| 2024-08-16 | Jain Vivek (Chairman and CEO) | Option Ex | 12,000 | 88.76 | 1,065,120 |
| 2024-08-08 | Sanzone Virginia Ruth (VP, General Counsel) | Sale | 2,050 | 144.11 | 295,425 |
| 2024-05-30 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 12,539 | 104.17 | 1,306,200 |
| 2024-05-16 | Finney Elisha W | Sale | 300 | 104.95 | 31,484 |
| 2024-05-15 | Hernandez Laurie (Director) | Option Ex | 948 | .00 | 0 |
| 2024-05-15 | Greenberg David C. (Director) | Option Ex | 948 | .00 | 0 |
| 2024-05-15 | Abbey Donald | Option Ex | 948 | .00 | 0 |
| 2024-05-15 | Kennedy Kolleen T | Option Ex | 948 | .00 | 0 |
| 2024-05-15 | Hoffmeister David F | Option Ex | 948 | .00 | 0 |
| 2024-05-15 | Finney Elisha W | Option Ex | 948 | .00 | 0 |
| 2024-05-10 | Sousa Ben (Chief Information Officer) | Sale | 2,000 | 105.55 | 211,090 |
| 2024-03-15 | Sousa Ben (Chief Information Officer) | Option Ex | 1,299 | .00 | 0 |
| 2024-03-15 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 3,247 | .00 | 0 |
| 2024-03-15 | Woolson Daniel (VP, GM-Infusion Capital) | Sale | 791 | 98.27 | 77,733 |
| 2024-03-15 | Woolson Daniel (VP, GM-Infusion Capital) | Option Ex | 2,923 | .00 | 0 |
| 2024-03-15 | Sanzone Virginia Ruth (VP, General Counsel) | Option Ex | 1,624 | .00 | 0 |
| 2024-03-15 | Jain Vivek (Chairman and CEO) | Option Ex | 4,871 | .00 | 0 |
| 2024-03-14 | Lopez George A (Director) | Sale | 7,978 | 101.87 | 812,742 |
| 2024-03-12 | Lopez George A (Director) | Sale | 1,522 | 101.51 | 154,496 |
| 2024-03-11 | Lopez George A (Director) | Sale | 1,890 | 104.22 | 196,968 |
| 2024-03-08 | Sousa Ben (Chief Information Officer) | Option Ex | 674 | .00 | 0 |
| 2024-03-08 | Bonnell Brian Michael (Chief Financial Officer) | Option Ex | 9,499 | .00 | 0 |
| 2024-03-08 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 9,499 | .00 | 0 |
| 2024-03-08 | Woolson Daniel (VP, GM-Infusion Capital) | Option Ex | 2,020 | .00 | 0 |
| 2024-03-08 | Jain Vivek (Chairman and CEO) | Option Ex | 10,856 | .00 | 0 |
| 2024-03-08 | Lopez George A (Director) | Sale | 15,372 | 105.94 | 1,628,448 |
| 2024-03-07 | Sousa Ben (Chief Information Officer) | Option Ex | 3,003 | .00 | 0 |
| 2024-03-07 | Bonnell Brian Michael (Chief Financial Officer) | Option Ex | 15,017 | .00 | 0 |
| 2024-03-07 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 15,017 | .00 | 0 |
| 2024-03-07 | Woolson Daniel (VP, GM-Infusion Capital) | Option Ex | 6,758 | .00 | 0 |
| 2024-03-07 | Jain Vivek (Chairman and CEO) | Option Ex | 22,524 | .00 | 0 |
| 2024-03-07 | Lopez George A (Director) | Sale | 18,954 | 105.77 | 2,004,707 |
| 2024-03-04 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 13,603 | 107.55 | 1,463,057 |
| 2024-03-04 | Lopez George A (Director) | Sale | 7,051 | 106.79 | 752,990 |
| 2024-02-29 | Smiths Group International Holdings Ltd | Sale | 830,000 | 106.08 | 88,042,250 |
| 2024-02-29 | Smiths Group Plc | Sale | 830,000 | 106.08 | 88,042,250 |
| 2024-02-12 | Jain Vivek (Chairman and CEO) | Option Ex | 212,366 | 58.79 | 12,484,997 |
| 2023-12-01 | Woolson Daniel (VP, GM-Infusion Capital) | Sale | 1,729 | 88.03 | 152,196 |
| 2023-09-08 | Voigtlander Christian B. (Chief Operating Officer) | Sale | 6,850 | 129.31 | 885,766 |
| 2023-07-12 | Jain Vivek (Chairman and CEO) | Sale | 30,000 | 180.02 | 5,400,720 |
| 2023-07-12 | Jain Vivek (Chairman and CEO) | Option Ex | 30,000 | 58.79 | 1,763,700 |
| 2023-06-14 | Jain Vivek (Chairman and CEO) | Sale | 30,000 | 190.21 | 5,706,270 |
| 2023-06-14 | Jain Vivek (Chairman and CEO) | Option Ex | 30,000 | 58.79 | 1,763,700 |
| 2023-06-07 | Finney Elisha W (Director) | Sale | 194 | 190.41 | 36,939 |
| 2023-05-17 | Hernandez Laurie (Director) | Option Ex | 485 | .00 | 0 |
| 2023-05-17 | Greenberg David C. (Director) | Option Ex | 485 | .00 | 0 |
| 2023-05-17 | Abbey Donald (Director) | Option Ex | 485 | .00 | 0 |
| 2023-05-17 | Kennedy Kolleen T (Director) | Option Ex | 485 | .00 | 0 |
| 2023-05-17 | Hoffmeister David F (Director) | Option Ex | 485 | .00 | 0 |
| 2023-05-17 | Finney Elisha W (Director) | Option Ex | 485 | .00 | 0 |
| 2023-04-11 | Sanzone Virginia Ruth (VP, General Counsel) | Sale | 250 | 175.00 | 43,750 |
| 2023-04-05 | Sanzone Virginia Ruth (VP, General Counsel) | Sale | 458 | 170.00 | 77,860 |
| 2023-03-08 | Bonnell Brian Michael (Chief Financial Officer) | Option Ex | 2,209 | .00 | 0 |
| 2023-03-08 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 2,209 | .00 | 0 |
| 2023-03-08 | Woolson Daniel (VP, GM-Infusion Capital) | Option Ex | 2,020 | .00 | 0 |
| 2023-03-08 | Sanzone Virginia Ruth (VP, General Counsel) | Option Ex | 2,272 | .00 | 0 |
| 2023-03-08 | Jain Vivek (Chairman and CEO) | Option Ex | 2,525 | .00 | 0 |
| 2023-03-07 | Bonnell Brian Michael (Chief Financial Officer) | Option Ex | 2,145 | .00 | 0 |
| 2023-03-07 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 2,145 | .00 | 0 |
| 2023-03-07 | Woolson Daniel (VP, GM-Infusion Capital) | Option Ex | 965 | .00 | 0 |
| 2023-03-07 | Sanzone Virginia Ruth (VP, General Counsel) | Option Ex | 1,072 | .00 | 0 |
| 2023-03-07 | Jain Vivek (Chairman and CEO) | Option Ex | 3,218 | .00 | 0 |
| 2023-03-06 | Bonnell Brian Michael (Chief Financial Officer) | Option Ex | 10,296 | .00 | 0 |
| 2023-03-06 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 10,296 | .00 | 0 |
| 2023-03-06 | Woolson Daniel (VP, GM-Infusion Capital) | Option Ex | 1,417 | .00 | 0 |
| 2023-03-06 | Sanzone Virginia Ruth (VP, General Counsel) | Option Ex | 1,595 | .00 | 0 |
| 2023-03-06 | Jain Vivek (Chairman and CEO) | Option Ex | 11,767 | .00 | 0 |
| 2023-02-02 | Woolson Daniel (VP, GM-Infusion Capital) | Sale | 1,731 | 200.00 | 346,200 |
| 2022-09-21 | Lopez George A (Director) | Option Ex | 79,576 | 61.76 | 4,914,613 |
| 2022-05-12 | Sanzone Virginia Ruth (VP, General Counsel) | Sale | 750 | 173.56 | 130,170 |
| 2022-05-12 | Finney Elisha W (Director) | Sale | 217 | 170.53 | 37,005 |
| 2022-05-12 | Lopez George A (Director) | Buy | 25,835 | 172.99 | 4,469,067 |
| 2022-05-11 | Hernandez Laurie (Director) | Option Ex | 352 | .00 | 0 |
| 2022-05-11 | Greenberg David C. (Director) | Option Ex | 433 | .00 | 0 |
| 2022-05-11 | Abbey Donald (Director) | Option Ex | 433 | .00 | 0 |
| 2022-05-11 | Kennedy Kolleen T (Director) | Option Ex | 129 | .00 | 0 |
| 2022-05-11 | Hoffmeister David F (Director) | Option Ex | 433 | .00 | 0 |
| 2022-05-11 | Finney Elisha W (Director) | Option Ex | 433 | .00 | 0 |
| 2022-03-08 | Bonnell Brian Michael (Chief Financial Officer) | Option Ex | 2,209 | .00 | 0 |
| 2022-03-08 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 2,209 | .00 | 0 |
| 2022-03-08 | Woolson Daniel (VP, GM-Infusion Capital) | Option Ex | 2,020 | .00 | 0 |
| 2022-03-08 | Sanzone Virginia Ruth (VP, General Counsel) | Option Ex | 2,272 | .00 | 0 |
| 2022-03-08 | Mcgrody Kevin J (Chief Accounting Officer) | Option Ex | 841 | .00 | 0 |
| 2022-03-08 | Jain Vivek (Chairman and CEO) | Option Ex | 2,524 | .00 | 0 |
| 2022-03-06 | Bonnell Brian Michael (Chief Financial Officer) | Option Ex | 2,273 | .00 | 0 |
| 2022-03-06 | Voigtlander Christian B. (Chief Operating Officer) | Option Ex | 2,995 | .00 | 0 |
| 2022-03-06 | Woolson Daniel (VP, GM-Infusion Capital) | Option Ex | 2,862 | .00 | 0 |
| 2022-03-06 | Sanzone Virginia Ruth (VP, General Counsel) | Option Ex | 3,039 | .00 | 0 |
| 2022-03-06 | Mcgrody Kevin J (Chief Accounting Officer) | Option Ex | 1,897 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of ICUI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Icu Medical Inc/de (symbol ICUI, CIK number 883984) see the Securities and Exchange Commission (SEC) website.